Outsourcing

Dec 13, 2017
By BioPharm International Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
Dec 01, 2017
BioPharm International
The Biomanufacturing Technology Roadmap is accelerating innovative manufacturing strategies for biopharmaceuticals.
Dec 08, 2017
By BioPharm International Editors
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
Dec 01, 2017
BioPharm International
Developing and retaining qualified employees will test biopharma companies and CMOs alike.
Dec 01, 2017
BioPharm International
Biopharma employees reveal employment objectives, opportunities, and frustrations.
Dec 07, 2017
An increasing number of warning letters shows that FDA is observing more problems with pharmaceutical contract manufacturing.
Dec 01, 2017
BioPharm International
In a productive year, 2017 was filled with acquisitions, facility expansions, and new biopharma technology.
Dec 06, 2017
By BioPharm International Editors
The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.
Dec 05, 2017
By BioPharm International Editors
Biopharma majors are among the industry stakeholders who have commented and raised questions about FDA’s recently proposed draft guidance for analytical assessment of similarity in biosimilars.
Dec 01, 2017
By BioPharm International Editors
Lonza has entered into strategic license agreements for exclusive rights to a gene-therapy platform for developing treatments for hearing and balance disorders.
native1_300x100
lorem ipsum